• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定腰椎手术失败综合征患者药物量化量表III及吗啡毫克当量的最小临床重要差异。

Determining the Minimal Clinical Important Difference for Medication Quantification Scale III and Morphine Milligram Equivalents in Patients with Failed Back Surgery Syndrome.

作者信息

Goudman Lisa, Smedt Ann De, Forget Patrice, Moens Maarten

机构信息

Department of Neurosurgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Jette, Belgium.

Center for Neurosciences (C4N), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium.

出版信息

J Clin Med. 2020 Nov 21;9(11):3747. doi: 10.3390/jcm9113747.

DOI:10.3390/jcm9113747
PMID:33233343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7700681/
Abstract

The Medication Quantification Scale III (MQS) is a tool to represent the negative impact of medication. A reduction in medication can serve as an indicator to evaluate treatment success. However, no cut-off value has yet been determined to evaluate whether a decrease in medication is clinically relevant. Therefore, the objective is to estimate the thresholds for the MQS and morphine milligram equivalents (MMEs) that best identify a clinically relevant important improvement for patients. Data from the Discover registry, in which patients with failed back surgery syndrome were treated with high-dose spinal cord stimulation, were used. Patient satisfaction was utilized to evaluate a clinically important outcome 12 months after stimulation. Anchor-based and distribution-based methods were applied to determine the minimal clinical important difference (MCID). Distribution-based methods revealed a value of 4.28 for the MQS and 33.61 for the MME as MCID. Anchor-based methods indicated a percentage change score of 41.2% for the MQS and 28.2% for the MME or an absolute change score of 4.72 for the MQS and 22.65 for the MME. For assessing a treatment outcome, we recommend using the percentage change score, which better reflects a clinically important outcome and is not severely influenced by high medication intake at baseline.

摘要

药物量化量表III(MQS)是一种反映药物负面影响的工具。药物减少可作为评估治疗成功与否的指标。然而,尚未确定用于评估药物减少是否具有临床相关性的临界值。因此,目的是估计MQS和吗啡毫克当量(MME)的阈值,以最佳地识别患者临床上相关的重要改善情况。使用了来自发现登记处的数据,其中接受高剂量脊髓刺激治疗的腰椎手术失败综合征患者参与了该研究。利用患者满意度来评估刺激后12个月的临床重要结果。采用基于锚定和基于分布的方法来确定最小临床重要差异(MCID)。基于分布的方法显示,MQS的MCID值为4.28,MME的MCID值为33.61。基于锚定的方法表明,MQS的百分比变化评分为41.2%,MME的百分比变化评分为28.2%;或MQS的绝对变化评分为4.72,MME的绝对变化评分为22.65。为了评估治疗结果,我们建议使用百分比变化评分,它能更好地反映临床重要结果,且不受基线时高药物摄入量的严重影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da4f/7700681/18088374bc53/jcm-09-03747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da4f/7700681/e533c5774511/jcm-09-03747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da4f/7700681/18088374bc53/jcm-09-03747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da4f/7700681/e533c5774511/jcm-09-03747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da4f/7700681/18088374bc53/jcm-09-03747-g002.jpg

相似文献

1
Determining the Minimal Clinical Important Difference for Medication Quantification Scale III and Morphine Milligram Equivalents in Patients with Failed Back Surgery Syndrome.确定腰椎手术失败综合征患者药物量化量表III及吗啡毫克当量的最小临床重要差异。
J Clin Med. 2020 Nov 21;9(11):3747. doi: 10.3390/jcm9113747.
2
Follow-up score, change score or percentage change score for determining clinical important outcome following surgery? An observational study from the Norwegian registry for Spine surgery evaluating patient reported outcome measures in lumbar spinal stenosis and lumbar degenerative spondylolisthesis.随访评分、变化评分或百分比变化评分用于确定手术后的临床重要结局?一项来自挪威脊柱外科登记处的观察性研究,评估了腰椎管狭窄症和腰椎退行性滑脱患者报告的结局测量指标。
BMC Musculoskelet Disord. 2019 Jan 18;20(1):31. doi: 10.1186/s12891-018-2386-y.
3
What is the Minimum Clinically Important Difference for the WOMAC Index After TKA?全膝关节置换术后 WOMAC 指数的最小临床重要差异是多少?
Clin Orthop Relat Res. 2018 Oct;476(10):2005-2014. doi: 10.1097/CORR.0000000000000444.
4
Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.评估随时间推移的健康状况:回顾期和锚定问题对 COPD 健康状况工具的最小临床重要差异的影响。
Health Qual Life Outcomes. 2018 Jun 26;16(1):130. doi: 10.1186/s12955-018-0950-7.
5
Minimal Clinically Important Differences for American Orthopaedic Foot & Ankle Society Score in Hallux Valgus Surgery.拇外翻手术中美国矫形足踝协会评分的最小临床重要差异
Foot Ankle Int. 2017 May;38(5):551-557. doi: 10.1177/1071100716688724. Epub 2017 Feb 13.
6
What Change in American Shoulder and Elbow Surgeons Score Represents a Clinically Important Change After Shoulder Arthroplasty?美国肩肘外科医生评分的何种变化代表着肩关节置换术后具有临床意义的变化?
Clin Orthop Relat Res. 2016 Dec;474(12):2672-2681. doi: 10.1007/s11999-016-4968-z. Epub 2016 Jul 8.
7
Determination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis.评估翻修融合术后因症状性假关节而导致的疼痛、残疾和生活质量的最小临床重要差异(MCID)。
Spine J. 2012 Dec;12(12):1122-8. doi: 10.1016/j.spinee.2012.10.006. Epub 2012 Nov 14.
8
What Are the Minimal and Substantial Improvements in the HOOS and KOOS and JR Versions After Total Joint Replacement?全膝关节置换术后 HOOS 和 KOOS 及 JR 版本的最小和实质性改善是什么?
Clin Orthop Relat Res. 2018 Dec;476(12):2432-2441. doi: 10.1097/CORR.0000000000000456.
9
What do spinal cord injury patients think of their improvement? A study of the minimal clinically important difference of the Spinal Cord Independence Measure III.脊髓损伤患者如何看待自己的改善?《脊髓独立性测量量表 III 的最小临床重要差异研究》。
Eur J Phys Rehabil Med. 2017 Aug;53(4):508-515. doi: 10.23736/S1973-9087.17.04240-X. Epub 2017 Jan 12.
10
Establishing Minimal Clinically Important Difference of Spinal Cord Stimulation Therapy in Post-Laminectomy Syndrome.建立脊髓电刺激疗法在后减压术后综合征中的最小临床重要差异。
Neurosurgery. 2017 Dec 1;81(6):1011-1015. doi: 10.1093/neuros/nyx153.

引用本文的文献

1
Comparison of opioid-sparing effect of liposomal vs. nonliposomal bupivacaine for interscalene block in total shoulder arthroplasty: a randomized controlled trial.脂质体布比卡因与非脂质体布比卡因在全肩关节置换术中肌间沟阻滞的阿片类药物节省效应比较:一项随机对照试验。
JSES Int. 2024 Nov 27;9(3):741-747. doi: 10.1016/j.jseint.2024.11.004. eCollection 2025 May.
2
An assessment of the minimal clinically important difference for the pain disability quality-of-Life Questionnaire-Spine.疼痛残疾生活质量问卷-脊柱的最小临床重要差异评估。
Interv Pain Med. 2022 Jul 8;1(3):100116. doi: 10.1016/j.inpm.2022.100116. eCollection 2022 Sep.
3

本文引用的文献

1
High-dose spinal cord stimulation for patients with failed back surgery syndrome: a multicenter effectiveness and prediction study.高剂量脊髓刺激治疗失败性腰椎手术综合征患者:一项多中心有效性和预测研究。
Pain. 2021 Feb 1;162(2):582-590. doi: 10.1097/j.pain.0000000000002035.
2
Composite Score Is a Better Reflection of Patient Response to Chronic Pain Therapy Compared With Pain Intensity Alone.与单纯的疼痛强度相比,综合评分能更好地反映患者对慢性疼痛治疗的反应。
Neuromodulation. 2021 Jan;24(1):68-75. doi: 10.1111/ner.13212. Epub 2020 Jun 27.
3
Moving Beyond a Pain Intensity Reporting: The Value of Goal Identification in Neuromodulation.
Percutaneous lumbar interbody fusion results in less perioperative opioid usage compared to minimally invasive transforaminal lumbar interbody fusion: a single institution, multi-surgeon retrospective study.
与微创经椎间孔腰椎椎间融合术相比,经皮腰椎椎间融合术的围手术期阿片类药物使用量更少:一项单机构、多外科医生的回顾性研究。
J Spine Surg. 2024 Jun 21;10(2):190-203. doi: 10.21037/jss-23-132. Epub 2024 May 17.
4
Sympathetic nerve blocks for persistent pain in adults with inoperable abdominopelvic cancer.成人无法手术的腹盆腔癌症持续性疼痛的交感神经阻滞。
Cochrane Database Syst Rev. 2024 Jun 6;6(6):CD015229. doi: 10.1002/14651858.CD015229.pub2.
5
Healthcare Utilization (HCU) Reduction with High-Frequency (10 kHz) Spinal Cord Stimulation (SCS) Therapy.高频(10千赫)脊髓刺激(SCS)疗法降低医疗保健利用率(HCU)
Healthcare (Basel). 2024 Mar 29;12(7):745. doi: 10.3390/healthcare12070745.
6
Large-scale real-world data on a multidisciplinary approach to spinal cord stimulation for persistent spinal pain syndromes: first evaluation of the Neuro-Pain nationwide screening and follow-up interactive register.关于脊髓刺激治疗持续性脊柱疼痛综合征的多学科方法的大规模真实世界数据:Neuro-Pain全国筛查和随访交互式登记册的首次评估
Front Neurosci. 2024 Mar 22;18:1322105. doi: 10.3389/fnins.2024.1322105. eCollection 2024.
7
An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry.基于英国医用大麻注册中心的大麻类药物治疗患者的临床疗效评估指标的观察性研究。
Neuropsychopharmacol Rep. 2023 Dec;43(4):616-632. doi: 10.1002/npr2.12403. Epub 2023 Dec 6.
8
Medical Cannabis Is Not Associated with a Decrease in Activities of Daily Living in Older Adults.医用大麻与老年人日常生活活动能力的下降无关。
Biomedicines. 2023 Oct 3;11(10):2697. doi: 10.3390/biomedicines11102697.
9
Intravenous Ketorolac Substantially Reduces Opioid Use and Length of Stay After Lumbar Fusion: A Randomized Controlled Trial.静脉注射酮咯酸可显著减少腰椎融合术后阿片类药物的使用和住院时间:一项随机对照试验。
Spine (Phila Pa 1976). 2024 Jan 15;49(2):73-80. doi: 10.1097/BRS.0000000000004831. Epub 2023 Sep 22.
10
Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry.纤维肌痛症患者的临床结局评估:来自英国医用大麻注册研究的分析。
Brain Behav. 2023 Jul;13(7):e3072. doi: 10.1002/brb3.3072. Epub 2023 May 18.
超越疼痛强度报告:神经调节中目标识别的价值。
Neuromodulation. 2020 Oct;23(7):1057-1058. doi: 10.1111/ner.13151. Epub 2020 Apr 8.
4
Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study.荷兰阿片类药物使用和滥用趋势:回顾性、多源数据库研究。
Lancet Public Health. 2019 Oct;4(10):e498-e505. doi: 10.1016/S2468-2667(19)30128-8. Epub 2019 Aug 20.
5
Understanding the Minimal Clinically Important Difference (MCID) of Patient-Reported Outcome Measures.了解患者报告结局测量的最小临床重要差异(MCID)。
Otolaryngol Head Neck Surg. 2019 Oct;161(4):551-560. doi: 10.1177/0194599819852604. Epub 2019 Jun 4.
6
The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis.脊髓刺激对减轻顽固性脊柱和肢体疼痛中止痛药物用量的影响:随机对照试验的系统评价和荟萃分析
J Pain Res. 2019 Apr 30;12:1311-1324. doi: 10.2147/JPR.S186662. eCollection 2019.
7
Follow-up score, change score or percentage change score for determining clinical important outcome following surgery? An observational study from the Norwegian registry for Spine surgery evaluating patient reported outcome measures in lumbar spinal stenosis and lumbar degenerative spondylolisthesis.随访评分、变化评分或百分比变化评分用于确定手术后的临床重要结局?一项来自挪威脊柱外科登记处的观察性研究,评估了腰椎管狭窄症和腰椎退行性滑脱患者报告的结局测量指标。
BMC Musculoskelet Disord. 2019 Jan 18;20(1):31. doi: 10.1186/s12891-018-2386-y.
8
Redefining Success: Longitudinal Patient Reported Outcome Measures and the Importance of Psychometric Testing for Optimization in Neuromodulation.重新定义成功:纵向患者报告结局测量以及神经调节优化中心理测量测试的重要性。
Neuromodulation. 2019 Jan;22(1):119-120. doi: 10.1111/ner.12907. Epub 2018 Dec 13.
9
Failed Back Surgery Syndrome: A Review Article.腰椎手术失败综合征:一篇综述文章。
Asian Spine J. 2018 Apr;12(2):372-379. doi: 10.4184/asj.2018.12.2.372. Epub 2018 Apr 16.
10
High-Density in Spinal Cord stimulation: Virtual Expert Registry (DISCOVER): Study Protocol for a Prospective Observational Trial.脊髓刺激中的高密度:虚拟专家注册研究(DISCOVER):一项前瞻性观察性试验的研究方案
Anesth Pain Med. 2017 May 30;7(3):e13640. doi: 10.5812/aapm.13640. eCollection 2017 Jun.